Delivery Order SPE2DB22D3501-SPE2DB25FUP81

Award Date 2/18/25
Potential Completion Date 2/19/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,339.92 firm fixed-price delivery order is for the supply of 4564858692 - VERAPAMIL 5 MG/2 ML VIAL 2ML, a cardiovascular medication. The contract has an ultimate completion date of June 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of verapamil 5 mg/2 ml vials. The firm-fixed-price delivery order, valued at $4,384.79, has a completion date of July 17, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, including a $999,999,999 IDC with the DLA Troop...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Verapamil 5 mg/2 ml vials. The potential value of the contract is $1,494.93, with a completion date of February 12, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to...
This federal contract award, with ID SPE2DX15D3012|SPE2DX24F8SL7, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of Verapamil 5 mg/2 ml vials, with a total ceiling value of $2,321.94. It is a firm fixed-price delivery order contract with an ultimate completion date of August 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Verapamil 5 mg/2 ml vials. The award has a completion date of March 1, 2024 and a potential value of $3,724.25. Amerisourcebergen Drug Corp is the prime contractor and there are no subcontractors mentioned. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen...
This federal contract award, valued at $2,108.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order (DO) under an Indefinite Delivery Contract (IDC), is for the supply of Verapamil 5 mg/2 ml vials. There is no set-aside designation for this award. The IDC held by Amerisourcebergen with the DLA Troop Support Medical is valued at $999,999,999 and runs through...
This is a $2,033.70 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of 4560632221 - VERAPAMIL 5 MG/2 ML VIAL 2ML. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products and supplies to federal agencies, including the military healthcare system. This delivery order...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,973.12, is for the delivery of Verapamil ER (extended-release) 100 mg capsules in quantities of 100s. This is a firm-fixed-price delivery order contract with a period of performance through June 7, 2024. The contract does not have a set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Verapamil 80 mg tablets. The $1,781.15 firm fixed price contract has an ultimate completion date of August 21, 2024. The award is not associated with a set-aside. AmerisourceBergen, the prime contractor, has extensive federal contracting experience, including an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
This federal contract award, valued at $1,815.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4567152563 - VERAPAMIL SR 240 MG CAPSULE 100S, a cardiovascular medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUP81
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,596.20, is for the delivery of verapamil 5 mg/2 ml vials. The contract has a completion date of February 19, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 5/22/25, 8:35 PM